• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS LIAT SYSTEM; RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS LIAT SYSTEM; RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM Back to Search Results
Catalog Number 07341920190
Device Problem False Positive Result (1227)
Patient Problems Anxiety (2328); Respiratory Tract Infection (2420); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/21/2021
Event Type  malfunction  
Event Description
A customer in (b)(6) alleged the generation of false positive results for 2 patient samples when tested with the cobas liat analyzer.It was noted the customer retests their positive samples on another cobas liat analyzer.No further details or data were provided.No harm was indicated.Two mdrs will be filed, one for each patient sample.
 
Manufacturer Narrative
The investigation is on-going.Supplemental reports will be filed upon completion of the investigation.The customer issue has been alleged on the cobas liat system, product code: occ, catalog number 07341920190 and udi (b)(4).The test used on the cobas liat system is the cobas sars-cov-2 & influenza a/b test for use on the cobas liat system ((b)(4), product code: qjr).The product catalog number for the test is 09211101190 and the udi is (b)(4).(b)(6).(b)(4).
 
Manufacturer Narrative
Roche has received an increased number of complaints from customers when using cobas® sars-cov-2 & influenza a/b test for use on the cobas® liat® system, lot 10119z.Customers are alleging an increased number of initial positive sars-cov-2 results that were negative upon retests on the same platform and/or on other platforms.Investigative testing using returned kits from the field generated an unexpected sars-cov-2 positive rate of 7% with known negative samples.Considering the involved hazards of the issue, there is a remote probability that use of the affected reagent lot will lead to adverse events in populations at greatest risk for infectious complications due to false positive sars-cov-2 results.Adverse health consequences are otherwise not likely.Consignees have been notified to immediately discontinue the use of and discard any remaining inventory of the cobas® sars-cov-2 & influenza a/b test for use on the cobas® liat® system, lot 10119z.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS LIAT SYSTEM
Type of Device
RESPIRATORY VIRUS PANEL NUCLEIC ACID ASSAY SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key12029661
MDR Text Key281010122
Report Number2243471-2021-02056
Device Sequence Number1
Product Code OCC
Combination Product (y/n)N
PMA/PMN Number
K111387
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 08/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07341920190
Date Manufacturer Received07/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number2243471-07-28-2021-002-C
Patient Sequence Number1
-
-